<DOC>
	<DOCNO>NCT03090191</DOCNO>
	<brief_summary>The Clover trial evaluate investigational vaccine may help prevent Clostridium difficile infection . Participants study adult 50 year age old , risk develop Clostridium difficile infection . The study ass whether vaccine prevents disease , whether safe well tolerate . Each subject receive 3 dos Clostridium difficile vaccine placebo follow 3 year vaccination potential Clostridium difficile infection .</brief_summary>
	<brief_title>Clostridium Difficile Vaccine Efficacy Trial</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Evidence personally sign date informed consent document . Willing able comply study procedure . Subjects increase risk future contact healthcare system subject received systemic antibiotic previous 12 week . Ability contact telephone study participation . Negative urine pregnancy test female subject childbearing potential . Investigator site staff member directly involved conduct study family member , site staff member otherwise supervised investigator , subject Pfizer employee , include family member , directly involve conduct study . Participation study involve investigational drug ( ) /vaccine ( ) within 28 day prior study entry 1 month third vaccination . Previous administration investigational C difficile vaccine C difficile mAb therapy . Prior episode CDI.. Receipt blood product immunoglobulins within 6 month enrollment . Subjects may unable respond vaccination due : Metastatic malignancy ; Endstage renal disease ; Any serious medical disorder likely fatal within next 12 month ; Congenital acquire immunodeficiency ; Receipt high dose systemic corticosteroid 14 day within 28 day enrollment ; Receipt chronic systemic treatment know immunosuppressant medication , radiotherapy , within 6 month enrollment . Known infection human immunodeficiency virus ( HIV ) . Any bleed disorder anticoagulant therapy would contraindicate intramuscular injection . Any contraindication vaccination vaccine component , include previous anaphylactic reaction vaccine vaccinerelated component . Prior small largebowel resection . Any condition treatment result frequent diarrhea . Other acute chronic condition abnormality may increase risk associate study participation IP administration may interfere interpretation study result Pregnant breastfeed female subject ; male subject female subject sexually active risk pregnancy not/ use 2 method contraception</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>